SOPHOS
Research type
Research Study
Full title
ScOttish Psoriatic arthritis Observational Study and biobank (SOPHOS)
IRAS ID
225864
Contact name
Stefan Siebert
Contact email
Sponsor organisation
NHS Great Glasgow & Clyde
Duration of Study in the UK
2 years, 11 months, 31 days
Research summary
Psoriatic arthritis (PsA) is a highly varied condition, ranging from relatively mild disease limited to one area to a severe arthritis affecting most joints. However, it is not currently possible to predict how PsA will develop in an individual, making it difficult to determine optimal treatment in early disease. Early stratification of patients with PsA is becoming particularly important as new therapies become available which preferentially target specific features of the disease. In order to help address this, all adult patients in Scotland with a new or recent onset (≤4 years) diagnosis of PsA will be invited to take part in the SOPHOS national cohort. Patients will be asked to have regular clinical follow up with prospective data collection every 6 months for two years and to contribute blood samples to the linked biobank for use now and in future research projects. It is hoped the clinical and molecular results will allow early prediction of future outcomes and facilitate stratification of patients to the most appropriate treatments.
REC name
London - Surrey Research Ethics Committee
REC reference
17/LO/1256
Date of REC Opinion
17 Jul 2017
REC opinion
Favourable Opinion